Clinical Impact of New Viral Hepatitis Data From AASLD 2022 *

November 4-8, 2022; Washington, DC
Get up to date on the latest practice-changing viral hepatitis data presented at AASLD 2022. Review key studies on HBV, HCV, and HDV; view on-demand webcasts; listen to the on-demand podcasts; download the slides; and read expert commentaries.

Share

Program Content

Activities

Viral Hepatitis AASLD 2022
Key Viral Hepatitis Studies Influencing My Practice Following AASLD 2022
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 16, 2022

Activities

AASLD 2022: US Perspective
My Take on Viral Hepatitis Treatment Advances From AASLD 2022: US Perspective
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: December 02, 2022

AASLD 2022: European Perspective
My Take on Viral Hepatitis Treatment Advances From AASLD 2022: European Perspective
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: December 05, 2022

No activities added yet

Activities

Viral Hepatitis at AASLD 2022: Newest Data
Newest Viral Hepatitis Data From AASLD 2022
Conference Coverage
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: December 06, 2022

Viral Hepatitis at AASLD 2022: Practice-Changing Data
Practice-Changing Viral Hepatitis Data From AASLD 2022
Conference Coverage
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: December 06, 2022

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Gilead Sciences, Inc.

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.